حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Sanofi India Limited
SANOFISanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH. Address: Sanofi House, Mumbai, India, 400072
Analytics
سعر الهدف في وول ستريت
684 962.24 INRنسبة السعر إلى الأرباح
26.8099العائد الربحي
2.72 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية SANOFI
تحليلات الأرباح SANOFI
نمو الأرباح على مدى 5 سنوات
430 %النمو المستمر
–معدل الدفع 5 سنوات في المتوسط
132 %تاريخ الأرباح SANOFI
تقييم الأسهم SANOFI
المالية SANOFI
نتائج | 2019 | ديناميات |